A New PARADIGM? Azacitidine-Venetoclax Tops Chemo in AML

Published Date: 10 Sep 2026

The less-intensive drug combination outperforms standard induction chemotherapy in fit patients with acute myeloid leukemia.

Read Full News

Latest News

FDA Approves Camizestrant for ESR1-Mutated Breast Cancer

The accelerated approval enables an endocrine therapy switch when the ESR1 resistance mutation is detected, rather than waiting for evidence of disease progression.

Talc Powder Not Linked to Lung Cancer in Women

A study of US women finds no connection between talc powder use and lung cancer, though subgroup findings leave questions open.

Saturated Fat Tied to Worse Survival After Prostate Cancer

The association is driven by higher rates of death from cardiovascular disease and other cancers over 13 years.

Medication Self-Injection Embraced by Breast Cancer Patients

Women with breast cancer show interest in self-injecting their medication.

Can 80 Gy Radiation Boost Survival in Prostate Cancer?

A modest increase in radiation dose improves progression-free survival over 10 years among men with high-risk prostate cancer — but the overall survival benefits found in a French trial are uncertain.

Remote CBT for Insomnia Improves Symptoms During Chemo

A new randomized trial strengthens the case for managing cancer-related insomnia with cognitive-behavioral therapy.

Todays Updates

The Market Forces Quietly Adding Thousands to Patient Bills

Over the past decade, the number of doctors working for hospitals rather than in private practice has more than doubled.

FDA Clears First Standalone Robotic Blood Draw System

A new robotic system is drawing blood in adult patients, but its real-world impact may depend on how often it skips difficult veins.

Roivant's Experimental Lung Disease Drug Meets Goals in Mid-stage Study

Roivant said on Tuesday its experimental drug met the main goals of a mid-stage study in patients ⁠with high blood pressure associated with a type of lung disease, sending...

Shared Decision-Making in Pediatric Lung Care

Effective communication, empathy amid medical uncertainty, and structured transition plans improve pediatric pulmonary care and the transition to adult care.

Advances in Care for Rare Pediatric Lung Diseases

Living with a rare lung condition can be especially challenging, but research into interogran cross talk and organoid models, and cross-border registry are improving outcomes.

The Future of Oncology Clinical Pathways in VHA

VA oncology Clinical Pathways logged 26,613 entries for 11,835 patients in FY25, standardizing care and paving the way to Oracle Health EHR.

Normal, but Not Optimal: Rethinking Perimenopause

In this roundtable, Drs Rachel Rubin, Makeba Williams, and Anna Cabeca discuss the changing landscape of perimenopause care — and why every clinician should join the conversation.

Todays Updates

The Market Forces Quietly Adding Thousands to Patient Bills

Over the past decade, the number of doctors working for hospitals rather than in private practice has more than doubled.

FDA Clears First Standalone Robotic Blood Draw System

A new robotic system is drawing blood in adult patients, but its real-world impact may depend on how often it skips difficult veins.

Roivant's Experimental Lung Disease Drug Meets Goals in Mid-stage Study

Roivant said on Tuesday its experimental drug met the main goals of a mid-stage study in patients ⁠with high blood pressure associated with a type of lung disease, sending...

Shared Decision-Making in Pediatric Lung Care

Effective communication, empathy amid medical uncertainty, and structured transition plans improve pediatric pulmonary care and the transition to adult care.

Advances in Care for Rare Pediatric Lung Diseases

Living with a rare lung condition can be especially challenging, but research into interogran cross talk and organoid models, and cross-border registry are improving outcomes.

The Future of Oncology Clinical Pathways in VHA

VA oncology Clinical Pathways logged 26,613 entries for 11,835 patients in FY25, standardizing care and paving the way to Oracle Health EHR.

Normal, but Not Optimal: Rethinking Perimenopause

In this roundtable, Drs Rachel Rubin, Makeba Williams, and Anna Cabeca discuss the changing landscape of perimenopause care — and why every clinician should join the conversation.

Latest News

The accelerated approval enables an endocrine therapy switch when the ESR1 resistance mutation is detected, rather than waiting for evidence of disease progression.

A study of US women finds no connection between talc powder use and lung cancer, though subgroup findings leave questions open.

The association is driven by higher rates of death from cardiovascular disease and other cancers over 13 years.

Women with breast cancer show interest in self-injecting their medication.

A modest increase in radiation dose improves progression-free survival over 10 years among men with high-risk prostate cancer — but the overall survival benefits found in a French trial are uncertain.

A new randomized trial strengthens the case for managing cancer-related insomnia with cognitive-behavioral therapy.

News All Time

Does Maintenance Therapy Extend Life in mCRC?

Maintenance therapy is linked to longer overall survival after first-line bevacizumab-based combination chemotherapy in patients with metastatic colorectal cancer, a study finds.

Preschoolers With Cancer Have Poor Motor Skills

Preschool children newly diagnosed with cancer exhibit significant motor impairments, reduced mobility, and weak grip strength at diagnosis, study shows.

Breast Cancer Survivors: Who Benefits From Weight-Loss Meds?

The oral drug naltrexone-bupropion helps some breast cancer survivors lose weight.

Fixed-Duration Combo Shows Promise for Relapsed MCL

Researchers examine the efficacy of fixed-duration mosunetuzumab plus polatuzumab vedotin in patients with heavily pretreated relapsed/refractory mantle cell lymphoma.

US Cancer Trials Heavily Favor Single Drugs Over Care Issues

Industry trials focus on single drugs, while publicly funded trials often look at broader cancer care. It’s a ‘complementary’ approach, but pharma enrolls over 90% of patients.

Ruxolitinib Reduces Acute GVHD in Transplant Patients

A phase 3 trial evaluates a low-dose ruxolitinib-based regimen for graft-vs-host disease prophylaxis among patients undergoing haploidentical hematopoietic stem-cell transplantation.

HCT Survival Outcomes Improving in Relapsed Hodgkin Lymphoma

Researchers evaluate changes in post-transplantation outcomes among patients with relapsed or refractory Hodgkin lymphoma from 2010 to 2022.

How Much of a Cancer Drug Is Too Much?

In a recent KFF survey, 43% of US adults said they had skipped their medication in the past year because of cost.

Belgian Algorithm Reshapes Endometrial Cancer Care

A new Belgian algorithm may help clinicians choose adjuvant therapy more precisely in early endometrial cancer, moving beyond TNM staging alone.

NPM1-Mutated AML: Not All Treatments Are Equal

Researchers conducted a retrospective analysis of patients with newly diagnosed NPM1-mutated AML treated with high- or low-intensity regimens.

Transgender Individuals Prefer HPV Self-Swabs

Transgender and gender-diverse individuals prefer self-collected HPV testing for cervical cancer screening, a new survey shows.

SBRT vs IMRT: Better for Bowel Symptoms, Not Cancer Control

For men with intermediate-risk prostate cancer, SBRT may beat longer-course radiotherapy in some measures of quality of life, but not disease-free survival.

FDA Approves Iberdomide Combo for Multiple Myeloma

Outcomes improve when a novel, first-in-class immunomodulatory drug is combined with daratumumab and dexamethasone in previously treated patients.

Can Electronic PRO Monitoring Ease Fatigue in Breast Cancer?

Weekly electronic symptom monitoring was associated with improved fatigue and physical functioning in a randomized trial of patients with metastatic breast cancer.

Wide Variation Seen in Lung Screening False-Positive Rates

US radiologists vary substantially in their reading of low-dose CT lung cancer screens, highlighting a need for measures to help standardize interpretation.

How Low Does PSA Need to Go in Metastatic Prostate Cancer?

A new real-world analysis helps clarify the most informative prognostic PSA benchmark in men with metastatic castration-sensitive prostate cancer.

Recommended News For You

A Cancer Patient's Cats Inspired a Push for Pets in Hospice Wards

Study: For predicting breast cancer, AI performs better than traditional risk models.

Ruxolitinib Reduces Acute GVHD in Transplant Patients

Racial differences seen in epigenetic age acceleration in childhood cancer survivors

Big PFS Increase in Advanced Neuroendocrine Tumors With Combination Therapy

Patients with resected head and neck cancers may benefit clinically from an investigational personalized vaccine.

Assisted Dying Under Scrutiny From Medscape's Readers

Recommended Articles For You

Bispecific Antibodies in DLBCL & Myeloma: Clinical Insights for Physicians 

What Is A High MCV Level? Causes, Symptoms, And Treatment Options 

Understanding Apoplexy: Symptoms, Causes, and Treatment Options  

What is Red Cell Distribution Width and Why Should You Care? 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Dementia-like protein buildup found in pancreas cells before cancer develops

2.

Highly Successful Treatment of Lynch Syndrome Patients with PD-1 Inhibitors for Colorectal Cancer.

3.

Survival rates for incurable larynx cancer investigated for first time

4.

NPM1-Mutated AML: Not All Treatments Are Equal

5.

Novel Agent for Chronic GVHD Wins FDA Approval

1.

Quality of Life Following Organ Function Preserving Oncologic Innovation

2.

Evolving Cancer Treatments: Innovations, Success Rates, and Mechanisms

3.

Prognostic Trajectories of Functional Recovery Following Major Hematologic Disorders

4.

Interpreting Iron Studies: What Your Blood Results Really Mean 

5.

Digital Oncology Command Platforms for Longitudinal Cancer Care Coordination

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

2.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

3.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V

4.

Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals

5.

How Multidisciplinary Teams Support Modern Cancer Care

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot